About Kritika Sarmah
Her interest in risky instruments and passion for writing made Kritika an analyst and financial journalist.
She earned her bachelor's degree in commerce and is currently pursuing the CFA program.
With her fundamental approach, she aims to help investors identify untapped investment opportunities.
Recent Articles By Kritika Sarmah
Exxon Mobil (XOM) Earnings Analysis: Ideal Time to Buy?
While the energy sector demonstrated resilience last year, falling natural gas prices could pose challenges this year. Industry leader Exxon Mobil (XOM) recently released its earnings, which paints an unclear picture. Let's analyze and find out if now could be an ideal time to buy the stock. Read on to find out...
GOOGL Earnings Breakdown and Optimizing Your Portfolio Strategy
With Alphabet's (GOOGL) earnings drawing near, investors eagerly await the potential earnings from its key services like Google Search, YouTube ad revenue, and Google Cloud. Join us as we delve into GOOGL's performance, offering insights to fine-tune your portfolio strategy...
Will MSFT Add Value to Your Watchlist During Earnings?
As Microsoft (MSFT) gears up to announce its earnings on April 25, investors are eagerly awaiting to see if the tech giant will continue to impress. Despite its robust emphasis on cloud services and strategic AI investments, MSFT's recent downturns in personal and gaming revenues have sparked concerns. Is MSFT poised to enhance your watchlist with its upcoming earnings report? Let's explore...
Is META Preparing for Market Momentum?
Anticipation is high in the market this week as investors look forward to Meta Platforms (META) unveiling its first-quarter results on Wednesday, April 24th. With bullish analysts' estimates and historic announcements, could META be on the verge of market momentum? Let us find out...
Does Charles Schwab's (SCHW) Q1 Performance Suggest a Buying Opportunity?
The first-quarter performance of The Charles Schwab Corporation (SCHW) has attracted considerable investor attention. But what lies beneath the surface? Let's dissect its fundamentals to ascertain whether it presents an enticing buying opportunity amidst today's market intricacies...
NVIDIA (NVDA) vs. Taiwan Semiconductor (TSM) - Which Chip Stock Will Dominate in Q2?
As technological advancements and investments increase, the chip industry anticipates significant benefits. While industry giants NVIDIA (NVDA) and Taiwan Semiconductor Manufacturing Company (TSM) are poised to capitalize on industry tailwinds, let's analyze which of these stocks is set for success in the second quarter...
3 Biotech Stocks to Buy to Power Through April
The biotech sector is primed for growth, fueled by a surge in FDA approvals, anticipated M&A deals, and the integration of AI in drug discovery. So, fundamentally sound biotech stocks Theratechnologies (THTX), Harmony Biosciences (HRMY), and Shionogi & Co. (SGIOY) might be solid buys in this month. Keep reading...
AMD vs. QCOM: Which Chip Stock Offers Better Investment Opportunities?
In the dynamic landscape of semiconductor investments, two prominent industry players, Advanced Micro Devices (AMD) and QUALCOMM (QCOM), vie for investor attention. With the semiconductor industry poised for substantial growth driven by robust chip demand across diverse sectors and bolstered by supportive government initiatives, both companies stand to benefit. However, which stock offers better investment opportunities? Let's find out…
JNJ Earnings Forecast - Is Pharmaceutical Industry Set for Shake-up?
As pharma titan Johnson & Johnson (JNJ) gears up to unveil its first-quarter results on April 16, 2024, anticipation looms over the pharmaceutical industry. JNJ’s recent acquisitions signal the company’s strategic expansions, and given its history as one of the prominent pharma companies, is JNJ’s forecast as stunning? Let us find out...